comprehensive -WSS

comprehensive

author：explore 2025-09-03 09:21:46 - browse：5

Golden brain and DNA spiral illustration. -- biotech coverage from STAT — Adobe

The dream of being able to pluck a cell therapy off of a freezer shelf and speedily give it to cancer patients is materializing in the cancer world. Now, a new biotech hopes to do the same for patients with neurological conditions.

Kenai Therapeutics closed a $82 million Series A round Thursday co-led by Cure Ventures, The Column Group, and sovereign wealth fund Alaska Permanent Fund Corp. The San Diego-based biotech has big plans for that money — it’s already identified its lead drug candidate for people with Parkinson’s disease, and plans to move into a clinical trial within the next year.

Kenai — pronounced key-nigh — is developing therapies that use induced pluripotent stem cells, or iPSCs. These highly versatile organisms are derived from skin or blood cells and can be transformed into any type of cell. In Parkinson’s, the idea is that these cells would replace damaged neurons.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

leisure time

WSS

Ebola: Gilead Sciences antiviral shows promise as new treatment

Vir antibody drug aimed at influenza A fails in clinical trial

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Pushing for an NIH office for post

Male and female sex labels in research insufficient, scientists say

FDA advisers back CAR

explore

comprehensive

Wikipedia

Activists slam private health insurers over coverage restrictions

Pushing for an NIH office for post

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Winning ticket for $1 billion Powerball jackpot sold in California

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Medical leaders decry Supreme Court decision on affirmative action

Why depression after traumatic brain injury is distinct

How one medical school became remarkably diverse

Divers poised to search for children washed away in Pennsylvania flash flood

focus

Study identifies new proteins linked to dementia risk 25 years later

John Green on his newest strategy for fighting tuberculosis

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Why scientists need input from humanists on sensitive research

Mass General totes up its waste in a move to tackle climate change

Readout Newsletter: CAR

focus

leisure time

focus

focus